RheumNow/LinkedIn
Jan 11, 2026, 09:58
Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
RheumNow shared a post on LinkedIn about a paper by Beatriz Grand et al. published in Lupus:
“100 women w/ severe preeclampsia (PE) compared to 40 pregnant controls. antiphospholipid antibodies (aPL) was significantly more prevalent in PE women (34% vs 10%) [OR = 4.63]. aPL positivity was also linked to both early and late severe PE [OR = 4-5, p = .008].”
Title: Exploring the association between preeclampsia and antiphospholipid antibodies. A prospective study
Authors: Beatriz Grand, Sebastián Udry, Andrea Avigliano, Mónica González Alcántara, José Omar Latino, Liliana Susana Voto
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 5, 2026, 12:57What the Future of Fertility Care May Look Like – Reproductive Medicine Associates
-
Sep 5, 2026, 12:51Raga Deepthi Ediga: Grateful to See Our Perspective on Metabolic Health and PCOS Featured on Fertility News
-
Sep 5, 2026, 12:43Aysha O’Connor: Why Can 5 Fertility Practitioners Give You 5 Completely Different Answers?
-
Sep 5, 2026, 12:33Chirag Bhandari: World Sexual Health Day – Making Sexual Health a Conversation, Not a Taboo
-
Sep 5, 2026, 12:21Jasmeet Kalra: Going Straight at the Infertility Taboo in India with Saarthak Bakshi
-
Sep 5, 2026, 12:13Shefali Shastri: Gloria Steinem’s Legacy Is the Reason We Get to Do This Work at All
-
Sep 5, 2026, 12:057 Fertility Myths You Believe Until It Matters – HomeIVF
-
Sep 4, 2026, 17:17Dan Annetts: The Fabulous CREATE Fertility Bristol Team This Week
-
Sep 4, 2026, 17:15Arsiak Vartenian: The Question I Wish Fertility Clinics Asked Women More…